Platforms & Technologies

Platform Partnerships

Almac Diagnostics offer clients a clinical trial diagnostic approach that allows the client to tailor their diagnostic requirements across multiple platform and chemistry options to suit their specific clinical trial needs.

We have strong partnerships with all of the major platform providers such as Illumina, Thermo Fisher, Qiagen, Archer and Nanostring.

Platform Partnerships

Our Range of Platform Technologies

Clients can choose from the following solutions when working with Almac Diagnostics to tailor the technology platform and chemistry to their clinical trial requirements.

DNA Analysis

  • Illumina MiSeq
  • Illumina NextSeq
    -Illumina TruSight Tumor 170
  • Thermo Fisher Ion Torrent PGM Dx
  • Sanger Sequencing
    -MSI
  • Nanostring nCounter
  • Fluidigm Biomark HD
  • Roche LightCycler
  • Qiagen RotorGene Q
  • Affymetrix
    -SNP 6.0, DMET, OncoScan

RNA Analysis

  • Illumina MiSeq
  • Illumina NextSeq
    – Illumina TruSeq RNA Exome 
  • Thermo Fisher Ion Torrent PGM Dx
  • Thermo Fisher/LifeTechnologies Quantstudio Dx
  • Roche LightCycler
  • Fluidigm BioMark HD
  • Nanostring nCounter
  • Qiagen RotorGene Q 
  • Affymetrix
    -RUO & DX V2 Genechip Systems
    -Xcel Array
    -Cancer DSA Arrays (Breast, Colorectal, Ovarian, Lung, Prostate)

Contact Us